Azure™ is a completely redesigned pacemaker with BlueSync™ technology for secure1 wireless communication via Bluetooth® Low Energy without compromising longevity.2
Azure also offers improved longevity,2 secure wireless alerts of clinically relevant events,1,3 accurate AT/AF detection,4 and proven AT/AF reduction algorithms such as Reactive ATP5 and updated MVP.6Product Details
Advisa MRI™ SureScan™ pacing systems are FDA approved for 1.5T and 3T full body MRI scans. Advisa DR is clinically proven to reduce the progression to permanent AF. Additionally, the Advisa SR is the latest addition to the SureScan family.Product Details
The miniaturized Micra™ AV and Micra™ VR transcatheter pacing systems (TPS) are the world’s smallest pacemakers7 for bradyarrhythmia management, delivered percutaneously via a minimally invasive approach without the use of leads.Product Details
This list does not include all of our past pacemakers. Visit our manuals website to find the device product manuals.
Medtronic Azure XT DR MRI SureScan Device Manual. M964338A001B. 2016-10-22.
Orenga M. Azure Longevity Increase Compared to Advisa. September 2017. Medtronic data on file.
Howard K. Alert Notification Timing. September 2017. Medtronic data on file.
Ziegler PD, et al. Accuracy of Atrial Fibrillation Detection in Implantable Pacemakers. Presented at HRS 2013 (PO02-08).
Hudnall H. Reactive Atrial-based Antitachycardia Pacing Therapy to Slow Progression of Atrial Fibrillation. August 2017, Medtronic data on file.
Gillis AM, et al. Reduction of unnecessary right ventricular pacing due to the managed ventricular pacing (MVP) mode in patients with symptomatic bradycardia. Benefit for both sinus node disease and AV block indications. Presented at HRS 2015 (Abstract AB21-1).
Nippoldt D, Whiting J. Micra Transcatheter Pacing System: Device Volume Characterization Comparison. November 2014. Medtronic data on file.